Are There Any Natural Remedies Proven to Alleviate Symptoms of Crested Wheatgrass Allergy?

What Is Crested Wheatgrass Allergy and Why Does It Happen?

Crested wheatgrass (Agropyron cristatum) is a cool-season perennial grass introduced across the North American Great Plains and Intermountain West for erosion control and livestock forage. Its airborne pollen shares cross-reactive proteins with other Pooideae subfamily grasses, including timothy, Kentucky bluegrass, and orchard grass. If you are sensitized to any of those species, your immune system will almost certainly react to crested wheatgrass pollen as well.

The Immunological Mechanism

When a sensitized person inhales crested wheatgrass pollen, IgE antibodies bound to mast cells and basophils recognize the allergen. Degranulation releases histamine, leukotrienes, and prostaglandins within minutes. The result is the classic triad of rhinorrhea, sneezing, and nasal congestion, often accompanied by ocular itching, tearing, and postnasal drip.

Grass-pollen allergens are grouped by the World Health Organization allergen nomenclature into groups 1 through 13. The group 1 allergens (Phl p 1 in timothy, Lol p 1 in rye) cross-react heavily across the Pooideae. This cross-reactivity is why research on timothy or perennial ryegrass immunotherapy applies directly to people reacting to crested wheatgrass.

Who Is at Highest Risk?

Sensitization rates to grass pollen in the United States run as high as 20 to 30 percent of the atopic population [1]. People living in dryland agricultural areas of Montana, Idaho, Wyoming, and the Canadian Prairie provinces face particularly high crested wheatgrass pollen loads during May and June. Those with concurrent asthma face an amplified lower-airway response and need more aggressive symptom control.

Does Saline Nasal Irrigation Actually Work?

Saline nasal irrigation is one of the most reliably studied non-pharmacological interventions for allergic rhinitis. A 2012 Cochrane review of nasal saline for chronic rhinosinusitis [2] and a 2016 RCT published in the Canadian Medical Association Journal (N=871) found that daily hypertonic saline irrigation reduced symptom scores and antihistamine use compared with no irrigation over 6 months [3].

How Saline Irrigation Works

The mechanism is mechanical. Irrigation physically removes pollen grains from nasal mucosa before they can bind to mast-cell-associated IgE. It also thins mucus, reduces mucosal edema, and may modestly lower local inflammatory mediator concentrations.

Practical Protocol

The standard Neti pot or squeeze-bottle protocol uses 240 mL of isotonic saline (9 g NaCl per liter of distilled or previously boiled water) once or twice daily during peak pollen season. Hypertonic formulations (18 to 21 g NaCl per liter) may produce greater symptom relief but cause more initial stinging. The ARIA 2021 guideline recommends nasal saline as an adjunct to pharmacological therapy rather than a standalone replacement [4].

Use only distilled, sterile, or boiled-then-cooled water. Tap water used directly in nasal irrigation has been associated with rare but serious Naegleria fowleri infections, as noted in multiple CDC advisories [5].

Quercetin: A Flavonoid With Mast-Cell Stabilizing Properties

Quercetin is a plant flavonoid present in onions, apples, and capers. In vitro studies show it inhibits histamine release from mast cells and downregulates interleukin-4 (IL-4) and IL-13 expression [6]. The clinical evidence in humans is smaller in scale than the saline data, but two placebo-controlled trials are worth examining.

What the Human Data Show

A 2020 double-blind RCT (N=92) published in Nutrients found that 500 mg quercetin daily for 8 weeks reduced total nasal symptom scores by 22 percent compared with 4 percent in the placebo arm (P<0.05) in subjects with seasonal allergic rhinitis [7]. A separate 2016 pilot trial (N=66) showed a statistically significant reduction in eye itching and sneezing at 4 weeks using a 400 mg quercetin-bromelain combination [6].

Dosing and Limitations

Standard research doses range from 400 to 1,000 mg daily in divided doses. Quercetin has low oral bioavailability, around 1 to 10 percent, which is why many commercial supplements include bromelain or phospholipid complexes to improve absorption. Neither formulation has been tested specifically against crested wheatgrass sensitization. The data extrapolate from broader grass-pollen or mixed-pollen populations.

Quercetin is generally safe at doses up to 1,000 mg per day for 12 weeks based on current human trial data. High doses above 1,000 mg daily may inhibit thyroid peroxidase, so people taking thyroid medications should discuss use with their physician before starting.

Butterbur (Petasites hybridus): Comparable to Cetirizine in One Trial

Butterbur is an herbaceous plant whose root extract contains petasins, compounds that inhibit leukotriene and histamine synthesis. A well-known 2002 RCT published in the BMJ (N=125) compared a standardized butterbur extract (Ze 339, 8 mg petasin per tablet, one tablet four times daily) against cetirizine 10 mg daily over 2 weeks in seasonal allergic rhinitis [8]. Both groups showed equivalent symptom score reductions, and butterbur produced fewer sedative side effects.

The Pyrrolizidine Alkaloid Safety Issue

Raw butterbur plants contain pyrrolizidine alkaloids (PAs), which are hepatotoxic and potentially carcinogenic. Only PA-free certified extracts (labeled "PA-free" or meeting European Pharmacopoeia standards) should be used. The European Medicines Agency evaluated butterbur safety and concluded that PA-free preparations appear acceptably safe for short-term use (up to 12 weeks) [9].

Products sold in the United States vary widely in PA content and are not consistently tested. Consumers should request a certificate of analysis confirming PA levels below the limit of detection (<0.1 parts per billion) before purchasing.

Who Should Not Use Butterbur

People with ragweed, marigold, or chrysanthemum allergies may cross-react with butterbur (same Asteraceae family). Pregnant or breastfeeding women, children under 12, and anyone with liver disease should avoid it entirely.

Probiotics and the Gut-Immune Axis

The hygiene hypothesis and more recent "old friends" hypothesis suggest that reduced microbial diversity in early life increases atopic disease risk. Can restoring that diversity with probiotics reduce active allergy symptoms?

Trial Evidence

A 2015 meta-analysis in Pediatric Allergy and Immunology covering 22 RCTs found that probiotic supplementation modestly reduced symptom scores and medication use in allergic rhinitis, though effect sizes were small and heterogeneity across strains was high [10]. The most studied strains include Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus GG, and Bifidobacterium longum BB536.

A 2018 double-blind RCT (N=173) in The American Journal of Clinical Nutrition tested L. Acidophilus L-92 (2x10^10 CFU daily) for 8 weeks during cedar pollen season and found a 15 percent reduction in nasal symptom scores compared with placebo (P<0.05) [11].

Practical Considerations

No trial has tested probiotics specifically for crested wheatgrass sensitization. Strain specificity matters enormously; a generic multi-strain capsule is not equivalent to the strains studied in trials. Fermented foods (yogurt with live cultures, kefir, kimchi) contribute to microbial diversity but at doses far lower than those used in trials.

Probiotics are safe for most adults but should be used cautiously in immunocompromised individuals.

Local Honey: Popular, but Evidence Is Thin

The idea behind local honey is that regular consumption of small amounts of local pollen embedded in honey could desensitize the immune system, functioning like low-dose oral immunotherapy.

A 2013 pilot RCT (N=40) published in Annals of Saudi Medicine compared locally sourced honey, commercial honey, and placebo in birch-pollen-sensitized patients [12]. Only locally sourced honey showed any difference from placebo, and the effect was modest and statistically marginal (P=0.04 on a single symptom subscale, non-significant on total symptom score). The study was underpowered and not replicated in crested wheatgrass populations.

Grass pollen is wind-pollinated and not primarily collected by bees during honey production. Beehive-sourced honey therefore contains minimal grass pollen, making the theoretical mechanism even weaker for grass allergies than for tree-pollen allergies.

Local honey is unlikely to cause harm for most people, but it should not replace effective treatments. Children under 12 months must not consume honey due to botulism risk.

Stinging Nettle (Urtica dioica): Modest Anti-Histamine Activity

Freeze-dried stinging nettle leaf has been used ethnobotanically for allergic conditions. A 1990 double-blind RCT (N=98) published in Planta Medica found that 300 mg freeze-dried nettle leaf twice daily reduced symptom ratings over one week in self-reported allergic rhinitis subjects, with 58 percent of the treatment group rating it moderately or highly effective versus 37 percent in placebo [13].

The study is old, small, and lacked validated allergy testing at enrollment. In vitro data suggest nettle extract inhibits prostaglandin formation and may partially block H1 receptors, but the magnitude of clinical effect is substantially smaller than that of a second-generation antihistamine such as fexofenadine 180 mg.

Nettle is generally recognized as safe at culinary doses. At higher supplemental doses, it may interact with anticoagulants and antihypertensive drugs due to its vitamin K content and mild diuretic properties.

The High-Evidence Option: Allergen Immunotherapy With Grass-Pollen Extracts

No natural remedy reviewed above changes the underlying immune response. Allergen immunotherapy does. For grass-pollen allergic rhinitis, both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) carry the strongest evidence base.

Subcutaneous Immunotherapy (SCIT)

SCIT involves injecting standardized grass-pollen extract (including Pooideae cross-reactive allergens) in escalating doses over 3 to 5 years. A 2010 Cochrane review of SCIT for seasonal allergic rhinitis (N=2,871 across 51 trials) found standardized mean difference of 0.73 in symptom scores favoring active SCIT (95% CI 0.57 to 0.90) and reduced medication use [14]. Treated patients maintained benefit for at least 3 years after stopping injections.

Sublingual Immunotherapy (SLIT)

Timothy grass SLIT tablets (Grastek, ALK-Abelló; Oralair, Stallergenes) have FDA approval and produce cross-reactive protection against crested wheatgrass and other Pooideae species due to shared group 1 and 5 allergens. The GRASSES trial (N=345) found that 3-year grass SLIT tablet therapy reduced rhinoconjunctivitis symptom-medication scores by 31 percent in the first season of treatment (P<0.001) compared with placebo [15].

The American Academy of Allergy, Asthma and Immunology (AAAAI) Practice Parameters state: "Subcutaneous allergen immunotherapy is disease-modifying therapy that can induce long-term remission of allergic disease." This is a level A recommendation backed by 50-plus randomized trials.

SLIT tablets require a prescription and carry a small risk of systemic allergic reactions. The first dose is administered in a physician's office. Patients self-administer at home thereafter.

Integrating Natural Remedies Into a Practical Allergy Plan

Most people with crested wheatgrass allergy will use a combination of approaches. The following framework reflects the clinical evidence gradient:

Tier 1 (high evidence, low risk): Saline nasal irrigation once or twice daily throughout pollen season. No prescription needed. Cost: approximately $10 to $20 for a season's supply.

Tier 2 (moderate evidence, low to moderate risk): Quercetin 500 mg twice daily starting 4 to 6 weeks before pollen season. PA-free butterbur Ze 339 equivalent, 8 mg petasin four times daily during symptomatic weeks. Discuss both with your physician if you take any prescription medications.

Tier 3 (weak or theoretical evidence): Probiotics with strains matching trial data (L. Acidophilus NCFM or BB536). Local honey as an adjunct only if tree-pollen rather than grass-pollen allergy is the primary concern.

Tier 4 (disease-modifying, prescription required): Grass-pollen SLIT tablets or SCIT administered by a board-certified allergist. The only intervention shown to alter the natural history of grass-pollen allergic disease and prevent new sensitizations.

Monitoring and When to Escalate

Mild seasonal sneezing and nasal congestion controlled with saline and antihistamines does not require urgent medical evaluation. Escalate promptly if:

• Symptoms persist despite two weeks of combination pharmacological and natural therapy.
• Wheezing, chest tightness, or shortness of breath accompanies nasal symptoms (suggesting allergic asthma).
• Skin testing or specific IgE blood testing (ImmunoCAP) has never been performed.
• Over-the-counter antihistamines cause intolerable sedation or provide inadequate relief.

A 2021 ARIA guideline update graded evidence for rhinitis management using a GRADE framework and recommended allergen immunotherapy for moderate-to-severe persistent or moderate-to-severe seasonal allergic rhinitis not adequately controlled by pharmacotherapy [4].

Spirometry or peak flow monitoring is warranted for anyone with grass-pollen allergy and concurrent asthma symptoms. The GINA 2023 guidelines recommend step-up asthma therapy if FEV1 falls below 80 percent predicted during pollen season [16].